» Articles » PMID: 33299310

Oral Exposure to ZnO Nanoparticles Disrupt the Structure of Bone in Young Rats Via the OPG/RANK/RANKL/IGF-1 Pathway

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2020 Dec 10
PMID 33299310
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the effects of ZnO NPs on bone growth in rats and explore the possible mechanisms of action.

Materials And Methods: Three-week-old male rats received ultrapure water or 68, 203, and 610 mg/kg zinc oxide nanoparticles (ZnO NPs) for 28 days, orally.

Results: The high-dosage groups caused significant differences in weight growth rate, body length, and tibia length (P<0.05), all decreasing with increased ZnO NP dosage. There were no significant differences in body mass index (BMI) (P>0.05). The zinc concentration in liver and bone tissue increased significantly with increased ZnO NP dosage (P<0.05). Clearly increased aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were observed in the 610 mg/kg ZnO NP group (P>0.05), whereas alkaline phosphatase (ALP) increased in the 610 mg/kg ZnO NP group (P<0.05). Significant differences in insulin-like growth factor type 1 (IGF-1) levels and a decrease in calcium (Ca) levels were observed in 203 and 610 mg/kg ZnO NP groups (P<0.05). Phosphorus (P) levels increased and the Ca/P ratio decreased in the 610 mg/kg ZnO NP group (P<0.05). Micro-computed tomography (micro-CT) of the tibia demonstrated signs of osteoporosis, such as decreased bone density, little trabecular bone structure and reduced cortical bone thickness. Micro-CT data further demonstrated significantly decreased bone mineral density (BMD), trabecular number (Tb.N), and relative bone volume (BV/TV) with increasing dosage of ZnO NPs. Osteoprotegerin (OPG) expression and the ratio of OPG to receptor activator of nuclear factor-κB ligand (RANKL) were statistically lower in the 610 mg/kg ZnO NP group (P<0.05), whereas RANKL expression did not change significantly (P>0.05).

Conclusion: We infer that ZnO NPs affect bone growth in young rats directly or indirectly by altering IGF-1 levels. Overall, the results indicate that ZnO NPs promote osteoclast activity and increase bone loss through the OPG/RANK/RANKL/IGF-1 pathway.

Citing Articles

The Effects of Microplastics on Musculoskeletal Disorder; A Narrative Review.

Fusagawa H, Youn A, Wilkerson E, Pandya N, Feeley B Curr Rev Musculoskelet Med. 2024; 18(2):39-47.

PMID: 39572502 PMC: 11775366. DOI: 10.1007/s12178-024-09932-9.


Characterization, dose dependent assessment of hepatorenal oxidative stress, hematological parameters and histopathological divulging of the hepatic damages induced by Zinc oxide nanoparticles (ZnO-NPs) in adult male Sprague Dawley rats.

Kausar S, Jabeen F, Latif M, Asad M Saudi J Biol Sci. 2023; 30(9):103745.

PMID: 37588571 PMC: 10425408. DOI: 10.1016/j.sjbs.2023.103745.


Nanoparticle Effects on Stress Response Pathways and Nanoparticle-Protein Interactions.

Cameron S, Sheng J, Hosseinian F, Willmore W Int J Mol Sci. 2022; 23(14).

PMID: 35887304 PMC: 9323783. DOI: 10.3390/ijms23147962.


Anatase and Rutile TiO Nanoparticles Lead Effective Bone Damage in Young Rat Model via the IGF-1 Signaling Pathway.

Cheng W, Xu X, Lang Y, Cheng Z, Rizwan M, Tang X Int J Nanomedicine. 2021; 16:7233-7247.

PMID: 34737562 PMC: 8558833. DOI: 10.2147/IJN.S333632.

References
1.
Guerra-Menendez L, Sadaba M, Puche J, Lavandera J, de Castro L, de Gortazar A . IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. J Transl Med. 2013; 11:271. PMC: 4231608. DOI: 10.1186/1479-5876-11-271. View

2.
Teng C, Jia J, Wang Z, Sharma V, Yan B . Size-dependent maternal-fetal transfer and fetal developmental toxicity of ZnO nanoparticles after oral exposures in pregnant mice. Ecotoxicol Environ Saf. 2019; 182:109439. DOI: 10.1016/j.ecoenv.2019.109439. View

3.
Yang H, Yan K, Yuping X, Zhang Q, Wang L, Gong F . Bone microarchitecture and volumetric bone density impairment in young male adults with childhood-onset growth hormone deficiency. Eur J Endocrinol. 2018; 180(2):145-153. PMC: 6347261. DOI: 10.1530/EJE-18-0711. View

4.
Chen X, Wang Z, Duan N, Zhu G, Schwarz E, Xie C . Osteoblast-osteoclast interactions. Connect Tissue Res. 2017; 59(2):99-107. PMC: 5612831. DOI: 10.1080/03008207.2017.1290085. View

5.
Mackie E, Ahmed Y, Tatarczuch L, Chen K, Mirams M . Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol. 2007; 40(1):46-62. DOI: 10.1016/j.biocel.2007.06.009. View